Neurelis Names CFO

San Diego-based Neurelis, a developer of therapeutics for the treatment of epilepsy and orphan neurologic disorders, says it has named a new CFO, among other executive moves. According to the company, it has named Brittany K. Bradrick as the company’s new cFO. Bradrick previously was COO and CFO at ViaCyte, and also served at Insulet and Abbott Diabetes Care, in addition to serving as an investment banker to the life science industry for 10 years at Piper Jaffray, Credit Suisse and Chase Securities.